165 related articles for article (PubMed ID: 37604640)
1.
Shi Y; Ren X; Cao S; Chen X; Yuan B; Brasil da Costa FH; Rodriguez Rosario AE; Corona A; Michikawa C; Veeramachaneni R; Osman AA; Xie T; Wang W; Sikora AG; Myers JN; Rangel R
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37604640
[TBL] [Abstract][Full Text] [Related]
2. Mutant p53 drives an immune cold tumor immune microenvironment in oral squamous cell carcinoma.
Shi Y; Xie T; Wang B; Wang R; Cai Y; Yuan B; Gleber-Netto FO; Tian X; Rodriguez-Rosario AE; Osman AA; Wang J; Pickering CR; Ren X; Sikora AG; Myers JN; Rangel R
Commun Biol; 2022 Jul; 5(1):757. PubMed ID: 35902768
[TBL] [Abstract][Full Text] [Related]
3. The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-naïve tumors with immune checkpoint inhibitors.
Tosi A; Parisatto B; Menegaldo A; Spinato G; Guido M; Del Mistro A; Bussani R; Zanconati F; Tofanelli M; Tirelli G; Boscolo-Rizzo P; Rosato A
J Exp Clin Cancer Res; 2022 Sep; 41(1):279. PubMed ID: 36123711
[TBL] [Abstract][Full Text] [Related]
4. HPV-positive murine oral squamous cell carcinoma: development and characterization of a new mouse tumor model for immunological studies.
Modic Z; Cemazar M; Markelc B; Cör A; Sersa G; Kranjc Brezar S; Jesenko T
J Transl Med; 2023 Jun; 21(1):376. PubMed ID: 37296466
[TBL] [Abstract][Full Text] [Related]
5. Functionally impactful TP53 mutations are associated with increased risk of extranodal extension in clinically advanced oral squamous cell carcinoma.
Gleber-Netto FO; Neskey D; Costa AFM; Kataria P; Rao X; Wang J; Kowalski LP; Pickering CR; Dias-Neto E; Myers JN
Cancer; 2020 Oct; 126(20):4498-4510. PubMed ID: 32797678
[TBL] [Abstract][Full Text] [Related]
6. A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma.
Shi C; Liu S; Tian X; Wang X; Gao P
BMC Cancer; 2021 Sep; 21(1):1035. PubMed ID: 34530752
[TBL] [Abstract][Full Text] [Related]
7. Comparing Genomic Landscapes of Oral and Cutaneous Squamous Cell Carcinoma of the Head and Neck: Quest for Novel Diagnostic Markers.
Gupta R; Strbenac D; Satgunaseelan L; Cheung VK; Narayanappa H; Ashford B; Mitchell J; Thind A; Palme CE; Ch'ng S; Low TH; Wykes J; Willet CE; Chew T; Yang J; Ranson M; Clark JR
Mod Pathol; 2023 Aug; 36(8):100190. PubMed ID: 37080394
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma.
Pratap Singh R; Kumari N; Gupta S; Jaiswal R; Mehrotra D; Singh S; Mukherjee S; Kumar R
Microbiol Spectr; 2023 Aug; 11(4):e0459622. PubMed ID: 37409975
[TBL] [Abstract][Full Text] [Related]
9. Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy.
Hanoteau A; Newton JM; Krupar R; Huang C; Liu HC; Gaspero A; Gartrell RD; Saenger YM; Hart TD; Santegoets SJ; Laoui D; Spanos C; Parikh F; Jayaraman P; Zhang B; Van der Burg SH; Van Ginderachter JA; Melief CJM; Sikora AG
J Immunother Cancer; 2019 Jan; 7(1):10. PubMed ID: 30646957
[TBL] [Abstract][Full Text] [Related]
10. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
11. Single-cell transcriptomics reveal the intratumoral landscape of infiltrated T-cell subpopulations in oral squamous cell carcinoma.
Chen J; Yang J; Li H; Yang Z; Zhang X; Li X; Wang J; Zhang Y; Chen S; Song M
Mol Oncol; 2021 Apr; 15(4):866-886. PubMed ID: 33513276
[TBL] [Abstract][Full Text] [Related]
12. Immune checkpoint CD161/LLT1-associated immunological landscape and diagnostic value in oral squamous cell carcinoma.
Hu X; Dong Y; Xie S; Song Y; Yu C; He Y; Wang Z; Hu Q; Ni Y; Ding L
J Pathol Clin Res; 2024 Mar; 10(2):e353. PubMed ID: 38502058
[TBL] [Abstract][Full Text] [Related]
13. Prevotella intermedia boosts OSCC progression through ISG15 upregulation: a new target for intervention.
Qin Y; Li Z; Liu T; Ma J; Liu H; Zhou Y; Wang S; Zhang L; Peng Q; Ye P; Duan N; Wang W; Wang X
J Cancer Res Clin Oncol; 2024 Apr; 150(4):206. PubMed ID: 38644421
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-23 receptor defines T helper 1-like regulatory T cells in oral squamous cell carcinoma.
Li W; An N; Wang M; Liu X; Mei Z
Immun Inflamm Dis; 2022 Dec; 10(12):e746. PubMed ID: 36444617
[TBL] [Abstract][Full Text] [Related]
15. Oral squamous cell carcinoma-derived EVs promote tumor progression by regulating inflammatory cytokines and the IL-17A-induced signaling pathway.
Li R; Zhou Y; Zhang M; Xie R; Duan N; Liu H; Qin Y; Ma J; Li Z; Ye P; Wang W; Wang X
Int Immunopharmacol; 2023 May; 118():110094. PubMed ID: 37030119
[TBL] [Abstract][Full Text] [Related]
16. Expansion of CD4+ cytotoxic T lymphocytes with specific gene expression patterns may contribute to suppression of tumor immunity in oral squamous cell carcinoma: single-cell analysis and
Chen H; Sameshima J; Yokomizo S; Sueyoshi T; Nagano H; Miyahara Y; Sakamoto T; Fujii S; Kiyoshima T; Guy T; Nakamura S; Moriyama M; Kaneko N; Kawano S
Front Immunol; 2023; 14():1305783. PubMed ID: 38077321
[TBL] [Abstract][Full Text] [Related]
17. Genomic and Transcriptomic Landscape of an Oral Squamous Cell Carcinoma Mouse Model for Immunotherapy.
Lee YM; Hsu CL; Chen YH; Ou DL; Hsu C; Tan CT
Cancer Immunol Res; 2023 Nov; 11(11):1553-1567. PubMed ID: 37669022
[TBL] [Abstract][Full Text] [Related]
18. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
Front Immunol; 2022; 13():922195. PubMed ID: 35935989
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of immune infiltrates in head and neck cancers across anatomical sites.
Muijlwijk T; Nijenhuis DNLM; Ganzevles SH; Brink A; Ke C; Fass JN; Rajamanickam V; Leemans CR; Koguchi Y; Fox BA; Poell JB; Brakenhoff RH; van de Ven R
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38212122
[TBL] [Abstract][Full Text] [Related]
20. The CXCL11-CXCR3A axis influences the infiltration of CD274 and IDO1 in oral squamous cell carcinoma.
Wang X; Zhang J; Zhou G
J Oral Pathol Med; 2021 Apr; 50(4):362-370. PubMed ID: 33187013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]